Digestive health is evolving beyond basic gut support as consumers increasingly connect the microbiome to broader wellness goals. As demand for science-backed solutions grows, brands need ingredients that deliver both clinical credibility and formulation flexibility.
Join this webinar to discover how Esflorin1® (Bifidobacterium longum CECT 7347) is helping shape the future of microbiome innovation through clinically studied probiotic and postbiotic solutions. Learn how one strain, available in two formats, can support product development across supplements, foods, and beverages while meeting consumer expectations for evidence-based digestive health solutions.
Key Takeaways
- Consumer trends driving the next generation of digestive health products
- The importance of strain-specific clinical evidence in microbiome innovation
- Clinical insights on Esflorin1® Probiotic and Postbiotic
- How probiotic and postbiotic formats can expand formulation opportunities
- Emerging research on the connection between the microbiome, digestive health, and beyond
Discover how clinically studied microbiome solutions can help build your products with credible science and consumer-friendly wellness offerings.
